Zilovertamab vedotin (MK 2140) in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Early results from the phase 2 waveLINE-004 study.

Basit Öğe Kaydı
dc.authorid0000-0001-9636-4113
dc.contributor.authorÖzcan, Muhit
dc.contributor.authorLee, Seung Tae
dc.contributor.authorMensah, Felix
dc.contributor.authorModi, Dipenkumar
dc.contributor.authorFossa, Alexander
dc.contributor.authorKim, Won Seog
dc.contributor.authorPaszkiewicz-Kozik, Ewa
dc.contributor.authorSevindik, Ömür Gökmen
dc.contributor.authorLavie, David
dc.date.accessioned2024-01-31T10:14:58Z
dc.date.available2024-01-31T10:14:58Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipMerck & Companyen_US
dc.identifier.citationÖzcan, M., Lee, S. T., Mensah, F., Modi, D., Fossa, A., Kim, W. S. ... Lavie, D. (2023). Zilovertamab vedotin (MK 2140) in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Early results from the phase 2 waveLINE-004 study. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 41(16). Chicago, IL, 02-06 June, 2023.
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue16
dc.identifier.scopusqualityN/A
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12223
dc.identifier.volume41
dc.identifier.wos001053772003474en_US
dc.identifier.wosqualityQ1
dc.indekslendigikaynakScopus
dc.institutionauthorSevindik, Ömür Gökmen
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO)en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectDLBCL
dc.subjectZilovertamab Vedotin (MK 2140)
dc.subjectRelapsed/Refractory (R/R)
dc.titleZilovertamab vedotin (MK 2140) in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Early results from the phase 2 waveLINE-004 study.
dc.typeConference Object

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Bildiri Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu